Bryan Bridgeman

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells”.

CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells

iScience(2021)10.1016/j.isci.2021.103348

N/A

0DataRank · unranked

20 citations

Jean‐Philippe Guégan, Christophe Ginestier, Assia Chaïbi, Alban Bessede, Emmanuelle Charafe‐Jauffret +14 more

Inhibition of Abelson Tyrosine-Protein Kinase 2 Suppresses the Development of Alcohol-Associated Liver Disease by Decreasing PPARgamma Expression

Cellular and Molecular Gastroenterology and Hepatology(2023)10.1016/j.jcmgh.2023.07.006

N/A

0DataRank · unranked

7 citations

Claudia R. Keating, Shaimaa A. Gad, Bryan Bridgeman, Aldeb Perera, Wei Hou +7 more

Monocarboxylate Transporter‐1 Is Dispensable for Hepatocellular Carcinoma Development

Molecular Carcinogenesis(2025)10.1002/mc.70021

N/A

0DataRank · unranked

1 citations

Bryan Bridgeman, Kyle Boedeker, Xianzhong Ding, Wei Qiu, Shaimaa A. Gad